Last Updated: Dec 10 2010 - Able2Act


Fact Sheet for Pfizer Inc

Nationality: United States
Compilation by Silobreaker
Although Silobreaker has relied on what it regards as reliable sources while compiling the content herein, Silobreaker cannot guarantee the accuracy, completeness, integrity or quality of such content and no responsibility is accepted by Silobreaker in respect of such content. Readers must determine for themselves what reliance they should place on the compiled content herein.

Related Stories

First reported 3 hours ago - Updated 2 hours ago - 2 reports

Pfizer gets Bombay HC approval for merger of Wyeth

Pfizer Ltd has announced that the High Court of Judicature at Bombay on October 31, 2014 considered and approved the amalgamation of Wyeth Limited with the Company, in terms of the scheme of amalgamation between Wyeth Limited, the Company and their respective ... [Published India Infoline - 2 hours ago]
First reported 8 hours ago - Updated 5 hours ago - 2 reports

J&J Bit Off More Than McNeil Could Chew In 2006 Pfizer OTC Acquisition

McNeil scaled up its manufacturing “volume and complexity substantially” following J&J’s acquisition of Pfizer’s consumer business in 2006, says McNeil Consumer VP Shane Freedman. “Just a few years later, we had the recalls” that led ...Related Biotechnology, ... [Published BioPortfolio - 5 hours ago]
First reported 7 hours ago - Updated 6 hours ago - 3 reports

Research and Markets: Global Pediatric Vaccine Market 2014-2018: Key Vendors are GlaxoSmithKline, Merck, Pfizer and Sanofi

First reported 18 hours ago - Updated 9 hours ago - 3 reports

US stock market daily report (October 30, 2014, Thursday)

accine against meningitis B - Trumenba (meningococcal group B vaccine) from Pfizer Inc. (PFE:NYSE) - was granted accelerated approval by the U.S. Food and Drug Administration on Wednesday, under their Breakthrough Therapy designation and Priority Review ... [Published Stock Markets Review - 9 hours ago]
First reported 21 hours ago - Updated 15 hours ago - 2 reports

Chemical Operator/Assistant (2nd Shift – 3:00pm – 11:30pm)

Org Marketing StatementAll over the world, Pfizer colleagues are working together to positively impact health for everyone, everywhere. Each position at Pfizer touches and contributes to the success of our business and our world. That’s why, as one of ... [Published PharmaDiversity - 15 hours ago]
First reported Oct 29 2014 - Updated 20 hours ago - 11 reports

Pink Sheet - Pfizer’s Meningitis B Vaccine Trumenba Is CBER’s First ‘Breakthrough’ Approval

FDA’s biologics center grants accelerated approval to the first U.S. vaccine targeting serogroup B meningococcal disease after a 4.5-month review; the vaccine is expected to come up for discussion, but not a vote, at CDC’s Advisory Committee on Immunization ... [Published Friends of Cancer Research - 20 hours ago]
First reported 23 hours ago - Updated 22 hours ago - 3 reports

Bridgestone hires Higgins as president of consumer tires

Bridgestone Americas Inc. has named TJ Higgins president, consumer U.S. and Canada, for Bridgestone Americas Tire Operations LLC. The hiring will be effective Nov. 3, 2014.Higgins brings more than 20 years of "big brand" consumer products marketing and ... [Published Modern Tire Dealer - 22 hours ago]
First reported Oct 29 2014 - Updated Oct 30 2014 - 6 reports

Pfizer reports positive Phase IV trial results of Pristiq to treat sexual dysfunction in MDD patients

Pfizer has reported positive results from its Phase IV clinical trial of Pristiq (desvenlafaxine) to treat sexual dysfunction in adults with major depressive disorder (MDD). ... [Published PBR - News - Oct 30 2014]
First reported Oct 29 2014 - Updated Oct 30 2014 - 4 reports

Pfizer meningitis vaccine wins U.S. approval

(Adds details on tests, safety findings) Oct 29 (Reuters) - Pfizer Inc has won U.S. approval for its Trumenba vaccine against meningitis B, a potentially deadly bacterial disease that has recently caused outbreaks on college campuses, the U.S. Food and ... [Published Sharenet - Oct 29 2014]
First reported Oct 29 2014 - Updated Oct 29 2014 - 4 reports

Pfizer Still Plans On Relocating Overseas To Save Costs And Boost Pipeline

Pfizer, suffering from a slowdown in revenue, is looking to strike a strategic acquisition deal through which it can lower its tax costs as well as boost pipelinePage 1 of 2Click Ticker to See live coveragePfizer Inc. ( PFE ) is not willing to take no ... [Published Bidness Etc - Oct 29 2014]
First reported Oct 29 2014 - Updated Oct 29 2014 - 3 reports

Pfizer Inc.'s Earnings: Emerging Market Growth and Patent Expirations Square Off

Source: Flickr user David Goehring.Big pharmaceutical companies are in the midst of dealing with the most sweeping patent cliff in their history, and Pfizer ( NYSE: PFE     ) is still dangling on the edge.Having lost Lipitor, Viagra, and a number of ... [Published Motley Fool Discussion Boards - Oct 29 2014]
First reported Oct 29 2014 - Updated Oct 29 2014 - 2 reports

Pfizer: Competition hits forecast

Pfizer, the biggest US pharmaceutical manufacturer, lowered its sales forecast for the second consecutive quarter, citing impending generic competition for its arthritis treatment, Celebrex.Read the full article here .This content was originally published ... [Published Global Advisors - Oct 29 2014]
In Focus
Network
Network

Blogs

sort by: Date | Relevance
Where Will Pfizer Go Next? [Published Wall St. Cheat Sheet - May 27 2014]
With shares of Pfizer ( NYSE:PFE ) trading around $29, is PFE an OUTPERFORM, WAIT AND SEE, or STAY AWAY? Let’s analyze the stock with the relevant sections of our CHEAT SHEET investing framework : T = Trends for a Stock’s Movement Pfizer is a biopharmaceutical ...
New Filings Reveal How Pfizer’s Executives Made... [Published Wall St. Cheat Sheet - May 17 2014]
Source: Thinkstock Even if Pfizer, Inc. ( NYSE:PFE ) doesn’t succeed in its bid for AstraZeneca Group Plc.  ( NYSE:AZN ), it seems Pfizer’s executives will be doing just fine. The Guardian reported on Friday that Pfizer’s executives have made ...
Is Pfizer Poised to Head Higher? [Published Wall St. Cheat Sheet - May 19 2014]
With shares of Pfizer ( NYSE:PFE ) trading around $29, is PFE an OUTPERFORM, WAIT AND SEE, or STAY AWAY? Let’s analyze the stock with the relevant sections of our CHEAT SHEET investing framework : T = Trends for a Stock’s Movement Pfizer is a biopharmaceutical ...
Pfizer: Time to Buy? [Published BARRONS.com Stocks To Watch Today - May 08 2014]
Yes, it’s time to buy Pfizer (PFE), according to Credit Suisse analyst Vamil Divan and team–especially if it can acquire AstraZeneca (AZN). They explain why: Reuters While 1Q results were disappointing, we believe the resulting weakness in [Pfizer] shares ...
Can Pfizer Break Higher? [Published Wall St. Cheat Sheet - Jun 02 2014]
With shares of Pfizer ( NYSE:PFE ) trading around $29, is PFE an OUTPERFORM, WAIT AND SEE, or STAY AWAY? Let’s analyze the stock with the relevant sections of our CHEAT SHEET investing framework : T = Trends for a Stock’s Movement Pfizer is a biopharmaceutical ...
1 2 3 4 5 6 7 8 9 10 ...

Audio/Video

sort by: Date | Relevance
Generics eat into Pfizer's sales [Published Reuters Video: Business - Jul 29 2014]
Pfizer's profit drops 15 pct [Published Reuters Video: Business - May 05 2014]
Pfizer to mount UK charm offensive [Published Reuters Video: Business - May 09 2014]
So why did AstraZeneca reject Pfizer? [Published Reuters Video: Business - May 19 2014]
Pfizer's bid is too bitter for Astra [Published Reuters Video: Business - May 19 2014]
1 2 3 4 5

Press Releases

sort by: Date | Relevance
STATEMENT REGARDING PFIZER ANNOUNCEMENT [Published GlobeNewswire: Acquisitions News - May 13 2014]
STATEMENT REGARDING PFIZER WITHDRAWAL [Published GlobeNewswire: Acquisitions News - May 27 2014]
CLARIFICATION REGARDING PFIZER STATEMENT [Published GlobeNewswire: Acquisitions News - May 20 2014]
Form 8 (OPD) Pfizer Inc. [Published GlobeNewswire: Advertising News - May 12 2014]
Fitch Affirms Pfizer's IDR at 'A+'; Outlook Stable [Published Fitch Ratings Headlines Corporate - Sep 26 2014]
1 2 3 4 5 6 7 8
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.